Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

MONDELEZ INTERNATIONAL INC Common StockTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

MONDELEZ INTERNATIONAL INC Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? MONDELEZ INTERNATIONAL INC Common Stock trades at $63.58 (market cap $78.49B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: MONDELEZ INTERNATIONAL INC Common Stock is far larger — about 53× uniQure N.V. Ordinary Shares's market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.38% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold MONDELEZ INTERNATIONAL INC Common Stock for 108 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

MDLZQURE
Market Cap
$78.49B$1.48B
Volume
7,021,9712,488,780
Sector
Consumer StaplesHealth
52-Week High
$64.99$70.59
52-Week Low
$51.51$9.03
Typical Hold Time
108 Days0 Days
Enterprise Value
$98.84B$728.62M
Dividend Yield
3.38%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MONDELEZ INTERNATIONAL INC Common Stock

Mondelez International (MDLZ) trades at $61.50, down 0.47% on the day, with strong technical momentum indicated by bullish moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue growth continues with $38.54 billion in 2025, though net income margin declined to 6.36% from 12.65% in 2024. Analyst consensus remains strongly bullish with a $70.29 price target, representing 14% upside potential.

MDLZ offers attractive valuation with a P/E of 22.53 and consistent dividend growth, recently raising its quarterly payout to $0.52. Key risks include cocoa cost pressures and margin compression, but the company's global brand strength and emerging market momentum provide stability. The stock presents a compelling opportunity for long-term investors seeking defensive exposure with dividend income.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDLZ
0% Buy100% Sell
Avg holding period · 108 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

About MONDELEZ INTERNATIONAL INC Common Stock

Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.

Read more on MDLZ →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →